The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

Flow Regulation by Opening the Septum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Sponsored by Occlutech US LLC (Switzerland)

Active
$515K Funding
4 People
External

Related Topics

Abstract

The purpose of this clinical study is to assess the safety and effectiveness of the Atrial Flow Regulator in the treatment of subjects, 18 years of age or older, who have symptomatic heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF) while on stable guideline directed medical therapy (GDMT) as outlined in the Guidelines for the Management of Heart Failure.

People